Oguchi Y, Morita I, Fujii T, Matsunaga K, Yoshikumi C, Kawai Y, Tsuru S, Nomoto K
Biomedical Research Laboratories, Kureha Chemical Industries Co., Ltd., Tokyo, Japan.
J Clin Lab Immunol. 1987 Oct;24(2):93-9.
In C3H/He mice, the weight and cell number of the thymus were reduced and the size distribution (scatter profile measured by flow cytometer) of the thymus cells was changed 1 week after subcutaneous inoculation of X5563 plasmacytoma. This involution and change were prevented by intraperitoneal or oral administration of PSK. We examined the mechanism of this involution and change in thymus and the effect of PSK on them. In X5563-bearing C3H/He mice, 3H-thymidine incorporation into the thymus was reduced compared with that in control mice, as evaluated not only per organ but also per 1 mg of thymus tissue. Such reduction was inhibited by PSK. The substance (IS substance) which possessed a suppressive activity against mitogen induced lymphocyte proliferation, was partially purified from the ascites of X5563-bearing mice by the combination of ammonium sulfate precipitation and Sephacryl S-200 chromatography. IS substance was demonstrated to suppress the antibody response and delayed type foot-pad response against sheep red blood cells in mice. The reduction of weight and cell number and the change of scatter profile in thymus were caused by injection of this substance even in tumor-free mice. The restorative effects of PSK were observed also in IS substance injected mice. These results suggested that the various changes in the thymus observed in tumor-bearing mice might be attributable to the suppression of cell proliferation in the thymus, that such suppression was caused at least partly by an immunosuppressive substance which possessed inhibitory activity against lymphocyte proliferation, and that PSK had an antagonistic activity against such a substance so as to restore the function of the thymus in tumor-bearing hosts.
在C3H/He小鼠中,皮下接种X5563浆细胞瘤1周后,胸腺重量和细胞数量减少,胸腺细胞的大小分布(通过流式细胞仪测量的散射图谱)发生改变。腹腔内或口服给予PSK可防止这种退化和改变。我们研究了胸腺这种退化和改变的机制以及PSK对它们的影响。在携带X5563的C3H/He小鼠中,与对照小鼠相比,不仅每个器官,而且每1mg胸腺组织中3H-胸腺嘧啶核苷掺入胸腺的量都减少了。PSK可抑制这种减少。通过硫酸铵沉淀和Sephacryl S-200色谱相结合的方法,从携带X5563的小鼠腹水中部分纯化出了对有丝分裂原诱导的淋巴细胞增殖具有抑制活性的物质(IS物质)。已证明IS物质可抑制小鼠对绵羊红细胞的抗体反应和迟发型足垫反应。即使在无肿瘤小鼠中,注射这种物质也会导致胸腺重量和细胞数量减少以及散射图谱改变。在注射了IS物质的小鼠中也观察到了PSK的恢复作用。这些结果表明,在荷瘤小鼠中观察到的胸腺各种变化可能归因于胸腺细胞增殖的抑制,这种抑制至少部分是由一种对淋巴细胞增殖具有抑制活性的免疫抑制物质引起的,并且PSK对这种物质具有拮抗活性,从而恢复荷瘤宿主胸腺的功能。